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Background
Breast carcinoma is a highly prevalent and incident dis-
ease. About half the observed cases are diagnosed in later
and/or disseminated disease stages. Treatment success in
advanced disease stage occurs in about 20% of cases. The
identification of patients who would most benefit from
neoadjunvant therapy can reduce treatment costs and
avoid adverse effects in patients with low probability of
response. However, is not yet possible to make such a
prediction. The cancer stem cells (CSCs) paradigm
relates a cell population resistant to radiotherapy, che-
motherapy and cells capable of tumor initiation and
recurrence. The identification and characterization of
CSCs in the primary tumor can be an effective method of
predicting response to neoadjuvant chemotherapy in
locally advanced breast cancer.
Materials and methods
We aim to include 40 patients diagnosed with invasive
ductal carcinoma, who will undergo neoadjuvant che-
motherapy before surgery. We are in process of collecting
tumor tissue biopsies and quantifying, by flow cytometry,
and separating, by FACS, the CSCs. We will define CSCs
genetic profiles and correlate them with pathological
response to the treatment. Biopsies have been collected
from five patients to date; from these samples, CSCs
were sorted and RNA was extracted and stored. We are
following patients for their clinical progress.
Results
To date, we did not observe statistical differences in the
percentage of CSCs in these five samples. We expect to
find transcriptional differences between CSCs in tumors
from patients who respond to neoadjuvant chemotherapy
and from patients who do not respond to treatment
regimens.
Conclusions
Although our preliminary data did not show differences,
we expect a slightly different percentage of CSCs in tumor
samples from responders vs. non-responders, in a larger
sample set. However, CSCs transcriptome differences
between the two groups of patients may yield a better
understanding of neoadjuvant chemotherapy resistance,
preventing unnecessary and costly treatment for many
patients.
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